Literature DB >> 29351463

Intermediary metabolism and fatty acid oxidation: novel targets of electron transport chain-driven injury during ischemia and reperfusion.

Qun Chen1, Masood Younus1, Jeremy Thompson1, Ying Hu1, John M Hollander2, Edward J Lesnefsky1,3,4,5.   

Abstract

Cardiac ischemia-reperfusion (I/R) damages the electron transport chain (ETC), causing mitochondrial and cardiomyocyte injury. Reversible blockade of the ETC at complex I during ischemia protects the ETC and decreases cardiac injury. In the present study, we used an unbiased proteomic approach to analyze the extent of ETC-driven mitochondrial injury during I/R. Isolated-perfused mouse (C57BL/6) hearts underwent 25-min global ischemia (37°C) and 30-min reperfusion. In treated hearts, amobarbital (2 mM) was given for 1 min before ischemia to rapidly and reversibly block the ETC at complex I. Mitochondria were isolated at the end of reperfusion and subjected to unbiased proteomic analysis using tryptic digestion followed by liquid chromatography-mass spectrometry with isotope tags for relative and absolute quantification. Amobarbital treatment decreased cardiac injury and protected respiration. I/R decreased the content ( P < 0.05) of multiple mitochondrial matrix enzymes involved in intermediary metabolism compared with the time control. The contents of several enzymes in fatty acid oxidation were decreased compared with the time control. Blockade of ETC during ischemia largely prevented the decreases. Thus, after I/R, not only the ETC but also multiple pathways of intermediary metabolism sustain damage initiated by the ETC. If these damaged mitochondria persist in the myocyte, they remain a potent stimulus for ongoing injury and the transition to cardiomyopathy during prolonged reperfusion. Modulation of ETC function during early reperfusion is a key strategy to preserve mitochondrial metabolism and to decrease persistent mitochondria-driven injury during longer periods of reperfusion that predispose to ventricular dysfunction and heart failure. NEW & NOTEWORTHY Ischemia-reperfusion (I/R) damages mitochondria, which could be protected by reversible blockade of the electron transport chain (ETC). Unbiased proteomics with isotope tags for relative and absolute quantification analyzed mitochondrial damage during I/R and found that multiple enzymes in the tricarboxylic acid cycle, fatty acid oxidation, and ETC decreased, which could be prevented by ETC blockade. Strategic ETC modulation can reduce mitochondrial damage and cardiac injury.

Entities:  

Keywords:  fatty acid oxidation; mitochondria; tricarboxylic acid cycle

Mesh:

Substances:

Year:  2017        PMID: 29351463      PMCID: PMC5966772          DOI: 10.1152/ajpheart.00531.2017

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  39 in total

1.  Inhibition of electron and energy transfer in mitochondria. I. Effects of Amytal, thiopental, rotenone, progesterone, and methylene glycol.

Authors:  B CHANCE; G R WILLIAMS; G HOLLUNGER
Journal:  J Biol Chem       Date:  1963-01       Impact factor: 5.157

2.  Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria.

Authors:  E J Lesnefsky; B Tandler; J Ye; T J Slabe; J Turkaly; C L Hoppel
Journal:  Am J Physiol       Date:  1997-09

3.  Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction.

Authors:  Walter A Baseler; Erinne R Dabkowski; Courtney L Williamson; Tara L Croston; Dharendra Thapa; Matthew J Powell; Trust T Razunguzwa; John M Hollander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

4.  Mitochondrial LON protease-dependent degradation of cytochrome c oxidase subunits under hypoxia and myocardial ischemia.

Authors:  Naresh B V Sepuri; Rajesh Angireddy; Satish Srinivasan; Manti Guha; Joseph Spear; Bin Lu; Hindupur K Anandatheerthavarada; Carolyn K Suzuki; Narayan G Avadhani
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-04-23       Impact factor: 3.991

5.  Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion.

Authors:  Qun Chen; Shadi Moghaddas; Charles L Hoppel; Edward J Lesnefsky
Journal:  J Pharmacol Exp Ther       Date:  2006-09-21       Impact factor: 4.030

6.  Reversible blockade of electron transport with amobarbital at the onset of reperfusion attenuates cardiac injury.

Authors:  Sarah Stewart; Edward J Lesnefsky; Qun Chen
Journal:  Transl Res       Date:  2009-03-12       Impact factor: 7.012

Review 7.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

8.  Cardioprotective effect of berberine against myocardial ischemia/reperfusion injury via attenuating mitochondrial dysfunction and apoptosis.

Authors:  Yongjun Wang; Jianzhen Liu; Airui Ma; Yanqiang Chen
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes.

Authors:  Erinne R Dabkowski; Walter A Baseler; Courtney L Williamson; Matthew Powell; Trust T Razunguzwa; Jefferson C Frisbee; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-11       Impact factor: 4.733

10.  Reversible blockade of complex I or inhibition of PKCβ reduces activation and mitochondria translocation of p66Shc to preserve cardiac function after ischemia.

Authors:  Meiying Yang; David F Stowe; Kenechukwu B Udoh; James S Heisner; Amadou K S Camara
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

View more
  13 in total

1.  Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway.

Authors:  Wei Lei; Yiqi Yan; Yaolei Ma; Min Jiang; Boli Zhang; Han Zhang; Yuhong Li
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

2.  The Commonalities and Differences in Mitochondrial Dysfunction Between ex vivo and in vivo Myocardial Global Ischemia Rat Heart Models: Implications for Donation After Circulatory Death Research.

Authors:  Mohammed Quader; Oluwatoyin Akande; Stefano Toldo; Renee Cholyway; Le Kang; Edward J Lesnefsky; Qun Chen
Journal:  Front Physiol       Date:  2020-06-23       Impact factor: 4.566

Review 3.  Mitoproteomics: Tackling Mitochondrial Dysfunction in Human Disease.

Authors:  María Gómez-Serrano; Emilio Camafeita; Marta Loureiro; Belén Peral
Journal:  Oxid Med Cell Longev       Date:  2018-11-08       Impact factor: 6.543

4.  Melatonin has profound effects on mitochondrial dynamics in myocardial ischaemia/reperfusion.

Authors:  K Dube; K Dhanabalan; R Salie; M Blignaut; B Huisamen; A Lochner
Journal:  Heliyon       Date:  2019-11-01

5.  Ischemia and reperfusion injury to mitochondria and cardiac function in donation after circulatory death hearts- an experimental study.

Authors:  Oluwatoyin Akande; Qun Chen; Stefano Toldo; Edward J Lesnefsky; Mohammed Quader
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

6.  Mitochondrial proteomics alterations in rat hearts following ischemia/reperfusion and diazoxide post‑conditioning.

Authors:  Yunchao Pan; Yuan Wang; Wenyan Shi; Yun Liu; Song Cao; Tian Yu
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

7.  Endoplasmic reticulum stress-induced complex I defect: Central role of calcium overload.

Authors:  Ahmed A Mohsin; Jeremy Thompson; Ying Hu; John Hollander; Edward J Lesnefsky; Qun Chen
Journal:  Arch Biochem Biophys       Date:  2020-02-12       Impact factor: 4.013

8.  Activation of mitochondrial calpain and increased cardiac injury: beyond AIF release.

Authors:  Jeremy Thompson; Ying Hu; Edward J Lesnefsky; Qun Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-04       Impact factor: 5.125

9.  Uncoupling protein 3 deficiency impairs myocardial fatty acid oxidation and contractile recovery following ischemia/reperfusion.

Authors:  Kristin S Edwards; Sadia Ashraf; Tyler M Lomax; Jessica M Wiseman; Michael E Hall; Fabio N Gava; John E Hall; Jonathan P Hosler; Romain Harmancey
Journal:  Basic Res Cardiol       Date:  2018-10-29       Impact factor: 17.165

10.  The role of Asprosin in patients with dilated cardiomyopathy.

Authors:  Ming-Shien Wen; Chao-Yung Wang; Jih-Kai Yeh; Chun-Chi Chen; Ming-Lung Tsai; Ming-Yun Ho; Kuo-Chun Hung; I-Chang Hsieh
Journal:  BMC Cardiovasc Disord       Date:  2020-09-07       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.